| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05583149 | Acalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas | Refractory Aggressive B-cell Lymphomas | Active, Not Recruiting | 2026-01-29 |
| Not applicable | ||||
| NCT07553572 | Remote Monitoring and Symptom Management Digital Application | Breast Cancer (Locally Advanced or Metastatic) | Recruiting | 2026-04-28 |
| NCT06665295 | THRIVE-CAR-T Digital App | CAR T-Cell Therapy | Recruiting | 2026-04-01 |
Breast Cancer (1) · Colorectal Cancer (1) · DLBCL (1) · Follicular Lymphoma (1) · Non-Hodgkin Lymphoma (1)